Markets:

Overview

News

Currencies

International

Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

4.320 -0.080 (-1.82%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

29 30 Next >

New Oral Film Tech Improving Cannabinoid Onset Seeks Patent Protection ↗

November 03, 2022

Pharmaceutical films leader IntelGenx Corp. (OTCQB: IGXT) filed a provisional patent application with the U.S.

Via Benzinga

Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S. ↗

November 03, 2022

Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis...

Via Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today ↗

November 02, 2022

GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:

Via Benzinga

Why Shares of atai Life Sciences Climbed 14.58% on Tuesday ↗

November 01, 2022

The company specializes in developing psychedelics as therapies.

Via The Motley Fool

atai Life Sciences to Participate in November Investor Events & Healthcare Conferences

November 01, 2022

From atai Life Sciences

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday ↗

November 02, 2022

Gainers

Via Benzinga

Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session ↗

November 01, 2022

Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.

Via Benzinga

atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business Update

November 01, 2022

From atai Life Sciences

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities ↗

October 31, 2022

(Part one of a four-part series)

Via Benzinga

A Sinister Reason May Be Behind Governors' Opposition To Cannabis Legalization ↗

October 28, 2022

As one Republican governor after another rejects President Biden’s suggestion to pardon simple cannabis possession convictions, one wonders what they're thinking.

Via Benzinga

October Recap: Major Psychedelic Drug Stocks Declined 9.9% ↗

October 27, 2022

In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD.

Via Talk Markets

Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 27, 2022

GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87

Via Benzinga

Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon ↗

October 26, 2022

Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing...

Via Benzinga

Psychedelic Stock Gainers And Losers From October 26, 2022 ↗

October 26, 2022

GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18

Via Benzinga

Psychedelic Stock Gainers And Losers From October 25, 2022 ↗

October 25, 2022

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39

Via Benzinga

Canadian Company's New Version Of Chemo-Induced Pain Treatment Is On FDA Track ↗

October 25, 2022

Drug delivery company IntelGenx Corp.

Via Benzinga

atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression

October 25, 2022

From atai Life Sciences

Via GlobeNewswire

Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week ↗

October 24, 2022

The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since...

Via Talk Markets

Allied, Small Pharma Among Top Psychedelic Movers Of Today ↗

October 21, 2022

GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53

Via Benzinga

atai Life Sciences Announces R&D Day Agenda

October 20, 2022

From atai Life Sciences

Via GlobeNewswire

Psychedelic Stock Gainers And Losers From October 18, 2022 ↗

October 18, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 18, 2022

During Tuesday's session, 78 companies made new 52-week lows.

Via Benzinga

Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology ↗

October 18, 2022

Clinical stage biopharma company atai Life Sciences (NASDAQ: ATAI) announced the initiation of the Phase 1 proof-of-concept (PoC) clinical trial of intranasal INB-01, a sol-gel based, excipient (

Via Benzinga

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial for Its Sol-gel Based Direct-to-Brain Drug Delivery Technology

October 18, 2022

From atai Life Sciences

Via GlobeNewswire

Psychedelic Stock Gainers And Losers From October 17, 2022 ↗

October 17, 2022

GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52

Via Benzinga

Small Pharma, Cybin Among Top Psychedelic Movers Of Today ↗

October 14, 2022

GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.12% at $0.12

Via Benzinga

Psychedelic Stock Gainers And Losers From October 12, 2022 ↗

October 12, 2022

GAINERS: Allied (OTC:ALID) shares closed up 48.05% at $0.48

Via Benzinga

Novel Psychedelic Compound Show Positive Results For Opioid Use Disorder Treatment ↗

October 12, 2022

Kratom grows in several Asian countries and has been traditionally used by local communities as a natural home remedy for pain, depression and addiction.

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.